Transition Therapeutics

September 24, 2015

Upcoming events: Lilly shoots for another diabetes win and TherapeuticsMD seeks VVA voom

Vantage point – Alzheimer’s researchers urge patience and earlier-stage patients

June 22, 2015

Event – Transition to agitation the solution for Elan cast-off

August 14, 2014

Upcoming events: Biogen targets MS again; Transition awaits Down syndrome data

March 03, 2014

Perrigo keeps Tysabri strategy behind a veil

February 08, 2013

Roche set to benefit from FDA effort to tackle Alzheimer’s paradox

August 13, 2012

Elan dresses up for a date, but single life beckons

April 04, 2011

Pharmasset the stand out small cap performer in first quarter

April 04, 2011

Pharmasset the stand out small cap performer in first quarter

January 04, 2011

Deals and financing over the Christmas period

August 10, 2010

Elan and Transition undaunted by efficacy findings for Alzheimer's drug

Load More